Mark Jen

Mark Jen is an Executive Group Medical Director at Genentech, bringing over 25 years of experience in clinical research and global drug development. They have held various leadership roles at Genentech, where they focused on the strategic development of first-in-human and proof-of-concept studies across several therapeutic areas, including infectious diseases and immunology. Previously, they served as the Deputy Division Director at the National Institute of Allergy and Infectious Diseases, where they directed multisite research networks for H1N1 influenza and HIV studies. Mark is currently pursuing a Master of Medicine at The Johns Hopkins University School of Medicine.